News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
667,395 Results
Type
Article (34556)
Company Profile (239)
Press Release (632589)
Multimedia
Podcasts (84)
Webinars (23)
Section
Business (212082)
Career Advice (1997)
Deals (32149)
Drug Delivery (132)
Drug Development (71315)
Employer Resources (166)
FDA (14515)
Job Trends (12637)
News (310739)
Policy (27856)
Tag
2025 Best Places to Work (16)
2026 Best Places to Work (27)
2027 BioCapital Standard (3)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (8)
2027 Biotech Beach Standard (5)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
40 Under 40 (3)
Academia (2196)
Academic (2)
Accelerated approval (59)
ADA (30)
Adcomms (34)
Allergies (190)
Alliances (45841)
ALS (223)
Alzheimer's disease (1687)
Antibody-drug conjugate (ADC) (630)
Approvals (15167)
Artificial intelligence (878)
ASCO (273)
Autoimmune disease (428)
Automation (72)
Bankruptcy (312)
Belgium (35)
Best Places to Work (9758)
BIO (67)
Biologics (110)
BIOSECURE Act (12)
Biosimilars (230)
BioSpace Insights (158)
Biotechnology (139)
Bispecific (53)
Bladder cancer (197)
Brain cancer (82)
Breast cancer (830)
Cancer (6553)
Cardiovascular disease (479)
Career advice (1690)
Career pathing (54)
CAR-T (361)
CDC (38)
CDMO (150)
Celiac Disease (3)
Cell-line development (1)
Cell therapy (974)
Cervical cancer (57)
Clinical research (64025)
Collaboration (2390)
Commercialization (57)
Company closure (4)
Compensation (1867)
Complete response letters (113)
COVID-19 (1967)
CRISPR (136)
CRO (6)
C-suite (1424)
Cystic fibrosis (150)
Data (9606)
Decentralized trials (3)
Denatured (37)
Depression (178)
Dermatology (177)
Diabetes (612)
Diagnostics (6665)
Digital health (61)
Diversity (11)
Diversity, equity & inclusion (40)
Drug discovery (420)
Drug pricing (94)
Drug shortages (14)
Duchenne muscular dystrophy (300)
Earnings (85640)
Editorial (35)
Employer branding (25)
Employer resources (146)
ESMO (371)
Events (112343)
Executive appointments (1156)
Eye disease (20)
FDA (18974)
Fibrodysplasia Ossificans Progressiva (14)
Fragile X (5)
Friedreich's ataxia (27)
Frontotemporal dementia (35)
Funding (1948)
Gene editing (273)
Generative AI (73)
Gene therapy (716)
GLP-1 (824)
Government (3048)
Grass and pollen (3)
Guidances (397)
Healthcare (14549)
Hematology (184)
HIV (106)
Huntington's disease (81)
Idiopathic pulmonary fibrosis (10)
IgA nephropathy (132)
Immunology and inflammation (241)
Immuno-oncology (127)
Indications (263)
Infectious disease (2304)
Inflammatory bowel disease (237)
Inflation Reduction Act (10)
Influenza (124)
Intellectual property (370)
Interviews (364)
IPO (15386)
IRA (22)
Job creations (3118)
Job search strategy (1356)
JPM (40)
Kidney cancer (23)
Kidney disease (141)
Labor market (129)
Layoffs (388)
Leadership (40)
Legal (6492)
Licensing (109)
Liver cancer (98)
Longevity (46)
Lung cancer (902)
Lung diease (17)
Lymphoma (464)
Machine learning (68)
Management (50)
Manufacturing (1213)
Marketing (38)
MASH (201)
Medical affairs (4)
Medical device (11809)
Medtech (12085)
Mergers & acquisitions (18225)
Metabolic disorders (1399)
Middle East (1)
mRNA (230)
Multiple sclerosis (219)
Multispecific (5)
NASH (17)
Netherlands (30)
Neurodegenerative disease (473)
Neuropsychiatric disorders (92)
Neuroscience (3395)
Neurotech (3)
NextGen: Class of 2026 (5052)
Non-profit (2722)
Now hiring (95)
Obesity (556)
Opinion (241)
Ovarian cancer (259)
Pain (267)
Pancreatic cancer (351)
Parkinson's disease (372)
Partnered (41)
Patents (735)
Patient advocacy (6)
Patient recruitment (795)
Patient selection (92)
Peanut (69)
People (55709)
Peptides (38)
Pharmaceutical (48)
Pharmacy benefit managers (16)
Phase 1 (20193)
Phase 2 (28018)
Phase 3 (21006)
Pipeline (12859)
Policy (215)
Postmarket research (2078)
Preclinical (8984)
Press Release (72)
Prostate cancer (327)
Psychedelics (73)
Radioligand (1)
Radiopharmaceuticals (341)
Rare diseases (1240)
Real estate (4987)
Recruiting (72)
Regenerative medicine (34)
Regulatory (24525)
Reports (88)
Research institute (2014)
Resumes & cover letters (395)
Rett syndrome (56)
RNA editing (30)
RSV (76)
Saudi Arabia (1)
Schizophrenia (183)
Series A (345)
Series B (229)
Service/supplier (9)
Sickle cell disease (124)
Special edition (22)
Spinal muscular atrophy (148)
Sponsored (46)
Startups (3436)
State (2)
Stem cells (5)
Stomach cancer (13)
Substance use disorders (19)
Supply chain (114)
Switzerland (13)
Tariffs (39)
Tax incentives (1)
The Weekly (46)
Vaccines (917)
Venture capital (141)
Weight loss (305)
Wet AMD (6)
Women's health (147)
Worklife (24)
Date
Today (201)
Last 7 days (801)
Last 30 days (3364)
Last 365 days (28029)
2026 (25414)
2025 (27101)
2024 (31686)
2023 (36484)
2022 (46391)
2021 (49768)
2020 (46604)
2019 (37193)
2018 (27783)
2017 (28034)
2016 (27315)
2015 (33526)
2014 (28291)
2013 (24382)
2012 (26283)
2011 (26913)
2010 (26136)
Location
Africa (626)
Alabama (103)
Alaska (5)
Arizona (422)
Arkansas (16)
Asia (34024)
Australia (5406)
California (15780)
Canada (4447)
China (1510)
Colorado (707)
Connecticut (646)
Delaware (437)
Europe (70670)
Florida (2319)
Georgia (516)
Hawaii (5)
Idaho (54)
Illinois (1127)
India (121)
Indiana (689)
Iowa (35)
Japan (671)
Kansas (136)
Kentucky (49)
Louisiana (43)
Maine (67)
Maryland (1711)
Massachusetts (11223)
Michigan (392)
Minnesota (863)
Mississippi (8)
Missouri (136)
Montana (28)
Nebraska (22)
Nevada (177)
New Hampshire (81)
New Jersey (3981)
New Mexico (30)
New York (4070)
North Carolina (1912)
North Dakota (13)
Northern California (8113)
Ohio (436)
Oklahoma (22)
Oregon (38)
Pennsylvania (3011)
Puerto Rico (29)
Rhode Island (58)
South America (890)
South Carolina (93)
South Dakota (1)
Southern California (6399)
Tennessee (193)
Texas (2626)
United States (54456)
Utah (493)
Vermont (2)
Virginia (318)
Washington D.C. (68)
Washington State (1256)
West Virginia (3)
Wisconsin (169)
Wyoming (5)
667,395 Results for "applied dna sciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Funding
Seawolf surfaces with $100M, $1.2B Sanofi pact for redosable DNA medicines
Backed by Novartis’ venture arm, Eli Lilly and CRISPR Therapeutics, Seawolf is advancing its nonviral DNA delivery platform while inking a pact with Sanofi.
November 16, 2026
·
1 min read
·
Gabrielle Masson
Press Releases
37th International Symposium on Human Identification (ISHI) Highlights Impact of Forensic DNA Science on Real Casework Examples
August 18, 2026
·
3 min read
Press Releases
Integrated DNA Technologies and Aldevron Launch New mRNA Solutions to Simplify Base and Prime Editing
November 4, 2026
·
6 min read
Press Releases
ProBio Sets New Standard in GMP Plasmid DNA Manufacturing with Guaranteed ≥ 85% Supercoiled DNA, Fixed-Cost, Clinical-Grade Delivered in Just 3 Months
November 1, 2026
·
4 min read
Press Releases
Researchers Gain Faster Access to Complex DNA as Integrated DNA Technologies and Ansa Biotechnologies Expand Ordering Platform
September 1, 2026
·
6 min read
Press Releases
Seawolf Therapeutics Debuts With $100 Million to Advance DNA-Based Therapeutics
November 16, 2026
·
3 min read
Press Releases
INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer’s Drug Research and Explore New Applications for XPro ™
October 14, 2026
·
1 min read
Press Releases
Applied DNA Sciences Closes up to $58 Million Private Placement; Announces Initial BNB Holdings Valued at Over $17 Million
October 23, 2025
·
6 min read
Press Releases
Applied Biologics Announces Research Collaboration with Dartmouth College Focused on Computational Protein Engineering
November 11, 2026
·
3 min read
Business
Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Results
Applied DNA Sciences, Inc., a leader in PCR-based DNA technologies, announced consolidated financial results for its second fiscal quarter ended March 31, 2024.
May 10, 2024
·
11 min read
1 of 66,740
Next